Data / Drug companies / Sennosides and docusate sodium
Sennosides and docusate sodium: 10 companies and 11 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Sennosides and docusate sodium is listed in the FDA National Drug Code Directory by 10 companies, with 11 products in commercial distribution. 0 of the products (0.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; tablet, film coated; tablet, coated, and the newest product started marketing on December 1, 2025.
The request: Get every company that lists sennosides and docusate sodium in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 10
- Products
- 11
- Generic (ANDA) products
- 0 (0.0%)
- Application numbers
- 2
- Routes
- Oral
- Brand names
- Senna-Plus, Senna-S, Senna Plus, Senna S, Senna-S
- openFDA record search
- api.fda.gov
Companies that list sennosides and docusate sodium
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Geri-Care Pharmaceuticals, Corp | 2 | tablet | Over the counter monograph drugs | May 1, 2019 |
| American Health Packaging | 1 | tablet | Over the counter monograph drugs | August 3, 2021 |
| Bryant Ranch Prepack | 1 | tablet | Over the counter monograph drugs | May 1, 2019 |
| Cardinal Health 107, LLC | 1 | tablet | Over the counter monograph drugs | August 3, 2021 |
| Medline Industries, LP | 1 | tablet, coated | Over the counter monograph drugs | May 22, 2018 |
| Meijer, Inc. | 1 | tablet | Over the counter monograph drugs | March 1, 2025 |
| Preferred Pharmaceuticals Inc. | 1 | tablet | Over the counter monograph drugs | December 11, 2024 |
| RMT Health LLC | 1 | tablet | Over the counter monograph drugs | December 1, 2025 |
| Strategic Sourcing Services LLC | 1 | tablet | Over the counter monograph drugs | May 1, 2023 |
| Time Cap Laboratories, Inc | 1 | tablet, film coated | Over the counter monograph drugs | January 1, 2010 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 9 | 81.8% |
| Tablet, film coated | 1 | 9.1% |
| Tablet, coated | 1 | 9.1% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 11 | 100% |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.